Hims & Hers Health, Inc. reported a record fourth quarter with a 97% increase in revenue year-over-year, reaching $167.2 million. The company also achieved Adjusted EBITDA profitability of $3.9 million and surpassed one million subscribers. For the full year 2022, revenue increased by 94% to $526.9 million.
Q4 2022 revenue reached a record $167.2 million, a 97% increase year-over-year.
The company achieved Adjusted EBITDA profitability of $3.9 million in Q4 2022.
Hims & Hers surpassed one million subscribers by the end of 2022, reflecting an 88% year-over-year growth.
Full year 2022 revenue totaled $526.9 million, up 94% year-over-year.
Hims & Hers provided financial outlook for Q1 2023 and full year 2023. For Q1 2023, the company expects revenue of $175 million to $180 million and Adjusted EBITDA of $3 million to $6 million. For the full year 2023, the company expects revenue of $735 million to $755 million and Adjusted EBITDA of $20 million to $30 million.
Visualization of income flow from segment revenue to net income